WASHINGTON, March 9 -- Sen. Chris Murphy issued the following press release:
U.S. Senator Chris Murphy (D-Conn.), a member of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, joined six Senate Democrats in an effort to continue seeking details from major pharmaceutical companies about their so-called deals with the Trump administration, in particular, any evidence that these deals will benefit American patients or lower drug prices.
"We write today to seek more information from [company] about which drugs are subject to the Medicaid components of your agreement with the Trump administration and whether the prices you will make available on these drugs are actually lower than the net pricing states currently receive...